Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

This article has a correction. Please see:

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 - December 01, 2019

XML

Correction

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Smith KN, Llosa NJ, Cottrell TR, et al

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Journal for ImmunoTherapy of Cancer 2019;7:63. doi: 10.1186/s40425-019-0547-7